Survey of Ophthalmology
Volume 49, Issue 2 , Pages 237-242, March 2004

Orbital leiomyoma: Report of a case and review of the literature

1Ocular Oncology Service, Department of Ophthalmology, and 2Department of Pathology, Ankara University Faculty of Medicine, Ankara, Turkey

MILTON BONIUK AND STEFAN SEREGARD, EDITORS

Abstract 

A 10-year-old female presented with slowly progressive proptosis of 1 year's duration. Orbital MRI revealed an extraconal oval mass occupying the lateral half of the mid and posterior orbit. The tumor was isointense to the extraocular muscle and cerebral gray matter on T1-weighted images and hyperintense on T2-weighted images. The patient underwent superolateral orbitotomy, and it was felt that the tumor was totally excised in a piecemeal fashion. Histopathologic examination showed that the tumor was composed of spindle cells arranged in a fibrous stroma rich in dilated sinusoidal capillaries. The nuclei of tumor cells were oval with blunted ends. There were no mitotic figures. Immunohistochemically, the tumor stained positive with smooth muscle actin, desmin, and vimentin. Based on the histopathologic and immunohistochemical staining results, a diagnosis of orbital leiomyoma was made. At 34 months follow-up, the patient continues to have 20/20 vision and is free of tumor recurrence clinically. Orbital leiomyoma is an uncommon tumor. Search of the English literature showed only 15 previous cases of orbital leiomyoma that have been published since 1963.

Keywords: Computed tomography, immunohistochemistry, leiomyoma, magnetic resonance imaging, orbit, pathology

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Presented as a case report at the Xth International Congress of Ocular Oncology, Amsterdam, the Netherlands, 17–21 June 2001. The authors reported no proprietary or commercial interest in any product mentioned or concept discussed in this article.

PII: S0039-6257(03)00184-X

doi:10.1016/j.survophthal.2003.12.010

Survey of Ophthalmology
Volume 49, Issue 2 , Pages 237-242, March 2004